Skip to content
Application 204849
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | HALOPERIDOL | HALOPERIDOL LACTATE | INJECTABLE;INJECTION | EQ 5MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 17478-110 | Haloperidol | Haloperidol Lactate | Akorn | ANDA | Current |
| 17478-110 | Haloperidol | Haloperidol Lactate | Akorn, Inc. | ANDA | Current |
| 17478-110 | Haloperidol | Haloperidol Lactate | Akorn, Inc. | ANDA | Current |
| 17478-110 | Haloperidol | Haloperidol Lactate | Akorn, Inc. | ANDA | Current |
| 17478-110 | Haloperidol | Haloperidol Lactate | Akorn, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 49701 | ORIG | 2017-09-08 |